David Hoover Named NTCA Vice President of Legislative Affairs

Targeted News Service |


ARLINGTON, Va., June 30 -- NTCA-The Rural Broadband Association issued the following news release: NTCA-The Rural Broadband Association, the premier national association representing nearly 900 independent, community-based telecommunications providers, announced today that David Hoover has been named vice president of legislative affairs and will oversee the association's strategic government relations initiatives beginning July 7. Prior to joining NTCA, Hoover served as director of government affairs for CTIA-The Wireless Association. He also served in leadership roles for the National Cable and Telecommunications Association, Legg Mason Precursor Group and a number of other research firms. Hoover has nearly 20 years of experience working in Washington, conducting research and analyzing federal policies, as well as building relationships with members of Congress, federal agencies and public interest groups in support of advocacy efforts. "David has a unique understanding of the financial and business model impacts of policymaking on telecommunications operators," said Shirley Bloomfield, NTCA chief executive officer. "We are thrilled to welcome him into this new role." Hoover earned a Master of Arts in Telecommunications from Michigan State University's College of Communications Arts & Sciences and a Bachelors of Science from Ohio University's E.W. Scripps School of Journalism. [Category: Telecommunications] TNS 24HariCha-140701-30FurigayJane-4784298 30FurigayJane

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of equities.com. Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to: http://www.equities.com/disclaimer

Companies

Symbol Name Price Change % Volume
VOXPY Veloxis Pharmaceuticals A S ADR n/a n/a n/a 0

Comments

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

Private Markets

CF0005, LLC dba Mesa-Marshall #1-2

MESA Resources, Inc. ("MESA") is sponsoring the development of the oil & gas well completion project "Mesa-Marshall #1-2". MESA, founded in 1992, is engaged in the acquisition, exploration and development…

Quants Inc

Quants, Inc, a California Corporation, develops, markets and operates financial technology platforms and alternative investment products offering sophisticated risk management since 2010. The Company has primarily sharpened its focus with…